BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33707311)

  • 1. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
    Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell-Specific Gene Promoters.
    Andreou T; Rippaus N; Wronski K; Williams J; Taggart D; Cherqui S; Sunderland A; Kartika YD; Egnuni T; Brownlie RJ; Mathew RK; Holmen SL; Fife C; Droop A; Lorger M
    J Natl Cancer Inst; 2020 Jun; 112(6):617-627. PubMed ID: 31501884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma.
    Xie Y; Chen L; Zhou J; Yang C; Xu C; Fan X; Tan Y; Wang Y; Kang C; Fang C
    Cancer Biol Med; 2020 Aug; 17(3):664-675. PubMed ID: 32944398
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
    Cui Y; Golob J; Kelleher E; Ye Z; Pardoll D; Cheng L
    Blood; 2002 Jan; 99(2):399-408. PubMed ID: 11781219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy.
    Noyan F; Díez IA; Hapke M; Klein C; Dewey RA
    Cancer Gene Ther; 2012 May; 19(5):352-7. PubMed ID: 22402626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
    Kwiatkowski SC; Guerrero PA; Hirota S; Chen Z; Morales JE; Aghi M; McCarty JH
    PLoS One; 2017; 12(9):e0185065. PubMed ID: 28938007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
    Nana AW; Yang PM; Lin HY
    Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy.
    Kao RL; Truscott LC; Chiou TT; Tsai W; Wu AM; De Oliveira SN
    Hum Gene Ther; 2019 Apr; 30(4):413-428. PubMed ID: 30860401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
    Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
    Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.
    Ma HI; Hueng DY; Shui HA; Han JM; Wang CH; Lai YH; Cheng SY; Xiao X; Chen MT; Yang YP
    Int J Mol Sci; 2014 Mar; 15(3):4393-414. PubMed ID: 24625664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.
    Xu Y; Stamenkovic I; Yu Q
    Cancer Res; 2010 Mar; 70(6):2455-64. PubMed ID: 20197461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCK promotes glioblastoma progression by TGFβ signaling.
    Wang Z; Ying C; Zhang A; Xu H; Jiang Y; Lou M
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
    Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
    Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
    Zhang C; Burger MC; Jennewein L; Genßler S; Schönfeld K; Zeiner P; Hattingen E; Harter PN; Mittelbronn M; Tonn T; Steinbach JP; Wels WS
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26640245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
    Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy.
    Hu Z; Robbins JS; Pister A; Zafar MB; Zhang ZW; Gupta J; Lee KJ; Newman K; Yun CO; Guise T; Seth P
    Cancer Gene Ther; 2010 Apr; 17(4):235-43. PubMed ID: 19798122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
    Lamano JB; Lamano JB; Li YD; DiDomenico JD; Choy W; Veliceasa D; Oyon DE; Fakurnejad S; Ampie L; Kesavabhotla K; Kaur R; Kaur G; Biyashev D; Unruh DJ; Horbinski CM; James CD; Parsa AT; Bloch O
    Clin Cancer Res; 2019 Jun; 25(12):3643-3657. PubMed ID: 30824583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cells.
    Lesniak MS; Kelleher E; Pardoll D; Cui Y
    Neurol Res; 2005 Dec; 27(8):820-6. PubMed ID: 16354542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.